Coya Therapeutics (COYA) News Today $6.26 +0.49 (+8.39%) Closing price 07/3/2025 03:52 PM EasternExtended Trading$6.05 -0.22 (-3.50%) As of 07/3/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock COYA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Coya Therapeutics resubmits IND application for ALS Phase 2 study to FDA - Investing.comJuly 2, 2025 | investing.comPositive Outlook for Coya Therapeutics, Inc. Driven by IND Resubmission and Promising Trial ResultsJuly 1, 2025 | tipranks.comCoya Therapeutics (NASDAQ:COYA) Given Buy Rating at Chardan CapitalJuly 1, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Trading Down 1.7% - Should You Sell?July 1, 2025 | marketbeat.comAfter myriad failures, a new wave of ALS drugs approachesJune 25, 2025 | finance.yahoo.comCoya Therapeutics Inc News - MorningstarJune 24, 2025 | morningstar.comMCoya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025June 18, 2025 | businesswire.comCoya Therapeutics: How Fair Value analysis predicted 40% downside in biotech stockJune 12, 2025 | uk.investing.comCoya Therapeutics (NASDAQ:COYA) Earns "Buy" Rating from HC WainwrightJune 9, 2025 | marketbeat.comCoya Therapeutics secures patent for IL-2 liquid formulationJune 4, 2025 | uk.investing.comEquities Analysts Offer Predictions for COYA Q3 EarningsMay 23, 2025 | marketbeat.comQ1 Earnings Estimate for COYA Issued By HC WainwrightMay 22, 2025 | marketbeat.comChardan Capital Has Negative Outlook of COYA FY2025 EarningsMay 21, 2025 | marketbeat.comCoya Therapeutics First Quarter 2025 Earnings: Misses ExpectationsMay 20, 2025 | finance.yahoo.comCoya Therapeutics: Promising Developments and Strategic Partnerships Drive Buy RatingMay 19, 2025 | tipranks.comCoya Therapeutics to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor ConferenceMay 16, 2025 | businesswire.comDME Capital Management LP Buys 372,414 Shares of Coya Therapeutics, Inc. (NASDAQ:COYA)May 10, 2025 | marketbeat.comCoya Therapeutics to Participate in Two Upcoming Conferences in May 2025May 8, 2025 | finance.yahoo.comSibylla Biotech Appoints Former Bayer CEO, Dieter Weinand, as Chairman of the Board of DirectorsMay 8, 2025 | globenewswire.comCoya Therapeutics (COYA) to Release Earnings on ThursdayMay 3, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Receives "Buy" Rating from Chardan CapitalApril 30, 2025 | marketbeat.comCoya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with ...April 26, 2025 | businesswire.comCoya Therapeutics: Treg Proof-Of-Concept Continues With Interim FTD Data ReleaseApril 25, 2025 | seekingalpha.comCoya Therapeutics reports interim results from IL-2, CTLA4-Ig combination studyApril 25, 2025 | markets.businessinsider.comPromising Outlook for Coya Therapeutics: Buy Rating Justified by Innovative Treatments and Pipeline PotentialApril 25, 2025 | tipranks.comCoya Therapeutics' (COYA) "Buy" Rating Reiterated at D. Boral CapitalApril 24, 2025 | marketbeat.comCoya Therapeutics Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection ...April 23, 2025 | seekingalpha.comCoya Therapeutics (NASDAQ:COYA) Trading 8.6% Higher - What's Next?April 23, 2025 | marketbeat.comAtea Pharmaceuticals appoints Howard Berman to board of directorsApril 17, 2025 | markets.businessinsider.comIs Coya Therapeutics (COYA) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?April 11, 2025 | insidermonkey.comIs Coya Therapeutics (COYA) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?April 11, 2025 | msn.comAIGH Capital Management LLC Grows Holdings in Coya Therapeutics, Inc. (NASDAQ:COYA)March 31, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Given "Buy" Rating at D. Boral CapitalMarch 28, 2025 | marketbeat.comChardan Capital Has Strong Forecast for COYA FY2025 EarningsMarch 28, 2025 | marketbeat.comCoya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome ProgramMarch 26, 2025 | businesswire.comCoya Therapeutics (NASDAQ:COYA) Earns "Buy" Rating from Chardan CapitalMarch 21, 2025 | marketbeat.comCoya Therapeutics Reports 2024 Financial Results and ProgressMarch 20, 2025 | tipranks.comCoya Therapeutics (NASDAQ:COYA) Is In A Good Position To Deliver On Growth PlansMarch 20, 2025 | finance.yahoo.comCoya Therapeutics (NASDAQ:COYA) Releases Quarterly Earnings Results, Beats Estimates By $0.14 EPSMarch 19, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Given Buy Rating at D. Boral CapitalMarch 19, 2025 | marketbeat.comCoya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial ResultsMarch 18, 2025 | finance.yahoo.comCoya Therapeutics Reports 2024 Financial Results and UpdatesMarch 18, 2025 | tipranks.comCoya Therapeutics (COYA) to Release Earnings on TuesdayMarch 11, 2025 | marketbeat.comD. Boral Capital Reiterates Buy Rating for Coya Therapeutics (NASDAQ:COYA)March 10, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Trading Up 4.5% - Should You Buy?March 4, 2025 | marketbeat.comCoya Therapeutics to Participate in KOL Call Hosted by BTIG to Discuss the Potential Treatment of Alzheimer’s Disease Using GLP-1 Agonists and CombinationsFebruary 26, 2025 | businesswire.comCoya Therapeutics to Participate in KOL Call Hosted by BTIG to Discuss the Potential Treatment of Alzheimer's Disease Using GLP-1 Agonists and CombinationsFebruary 25, 2025 | businesswire.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT), Biohaven Ltd. (BHVN) and Arvinas Holding Company (ARVN)February 12, 2025 | markets.businessinsider.com70,000 Shares in Coya Therapeutics, Inc. (NASDAQ:COYA) Bought by Newbridge Financial Services Group Inc.February 10, 2025 | marketbeat.comCoya Therapeutics Now Pivots Toward Phase 2 In ALS And FTDFebruary 7, 2025 | seekingalpha.com Get Coya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COYA and its competitors with MarketBeat's FREE daily newsletter. Email Address COYA Media Mentions By Week COYA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COYA News Sentiment▼0.440.58▲Average Medical News Sentiment COYA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COYA Articles This Week▼52▲COYA Articles Average Week Get Coya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fulcrum Therapeutics News Today iTeos Therapeutics News Today Revance Therapeutics News Today Eton Pharmaceuticals News Today Rezolute News Today CryoPort News Today Erasca News Today Vigil Neuroscience News Today Checkpoint Therapeutics News Today Tectonic Therapeutic News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COYA) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
